{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:55:21Z","timestamp":1792742121061,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background and aim<\/jats:title><jats:p>Cholangiocarcinoma (CCA) is a rare cancer, yet its incidence and mortality rates have been steadily increasing globally over the past few decades. Currently, there are no effective targeted treatment strategies available for patients. ACLY (ATP Citrate Lyase), a key enzyme in <jats:italic>de novo<\/jats:italic> lipogenesis, is aberrantly expressed in several tumors and is associated with malignant progression. However, its role and mechanisms in CCA have not yet been elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The expression of ACLY in CCA was assessed using transcriptomic profiles and tissue microarrays. Kaplan-Meier curves were employed to evaluate the prognostic significance of ACLY in CCA. Functional enrichment analysis was used to explore the potential mechanisms of ACLY in CCA. A series of assays were conducted to examine the effects of ACLY on the proliferation and migration of CCA cells. Ferroptosis inducers and inhibitors, along with lipid peroxide probes and MDA assay kits, were utilized to explore the role of ACLY in ferroptosis within CCA. Additionally, lipid-depleted fetal bovine serum and several fatty acids were used to evaluate the impact of fatty acids on ferroptosis induced by ACLY inhibition. Correlation analyses were performed to elucidate the relationship between ACLY and tumor stemness as well as tumor microenvironment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The expression of ACLY was found to be higher in CCA tissues compared to adjacent normal tissues. Patients with elevated ACLY expression demonstrated poorer overall survival outcomes. ACLY were closed associated with fatty acid metabolism and tumor-initiating cells. Knockdown of ACLY did not significantly impact the proliferation and migration of CCA cells. However, ACLY inhibition led to increased accumulation of lipid peroxides and enhanced sensitivity of CCA cells to ferroptosis inducers. Polyunsaturated fatty acids were observed to inhibit the proliferation of ACLY-knockdown cells; nonetheless, this inhibitory effect was diminished when the cells were cultured in medium supplemented with lipid-depleted fetal bovine serum. Additionally, ACLY expression was negatively correlated with immune cell infiltration and immune scores in CCA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ACLY promotes ferroptosis by disrupting the balance of saturated and unsaturated fatty acids. ACLY may therefore serve as a potential diagnostic and therapeutic target for CCA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1477267","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T04:24:05Z","timestamp":1727411045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The pathological significance and potential mechanism of ACLY in cholangiocarcinoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaoyan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi2465","article-title":"Inhibition of ACLY overcomes cancer immunotherapy resistance via polyu nsaturated fatty acids peroxidation and cGAS-STING activation","volume":"9","author":"Xiang","year":"2023","journal-title":"Sci Adv"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discovery"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq420","article-title":"Advances in the treatment of metastatic or unresectable biliary tract cancer","author":"Valle","year":"2010","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discovery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.09.001","article-title":"ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism","volume":"157","author":"Granchi","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00543-5","article-title":"Acetyl-CoA metabolism in cancer","volume":"23","author":"Guertin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B11","article-title":"ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma","volume":"8","author":"Qian","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2014.03.015","article-title":"Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth","volume":"349","author":"Gao","year":"2014","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.stem.2016.11.004","article-title":"Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells","volume":"20","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-08-1235","article-title":"ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer","volume":"68","author":"Migita","year":"2008","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2020.05.010","article-title":"ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Han","year":"2021","journal-title":"Hepatobil pancreatic Dis international: HBPD Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.gendis.2020.01.015","article-title":"ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis","volume":"8","author":"Adorno-Cruz","year":"2021","journal-title":"Genes Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","article-title":"Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis","volume":"187","author":"Qiu","year":"2024","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1038\/s41467-022-31963-4","article-title":"Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer","volume":"13","author":"Bartolacci","year":"2022","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.551051","article-title":"Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation","volume":"289","author":"Dufort","year":"2014","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13073-022-01143-6","article-title":"Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer","volume":"14","author":"Yang","year":"2022","journal-title":"Genome Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01462-z","article-title":"Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2587","article-title":"Apolipoproteins and cancer","volume":"8","author":"Ren","year":"2019","journal-title":"Cancer Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31412","article-title":"Apolipoprotein H-based prognostic risk correlates with liver lipid met abolism disorder in patients with HBV-related hepatocellular carcinoma","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01524","article-title":"Anti-tumorigenic and platinum-sensitizing effects of apolipoprotein A1 and apolipoprotein A1 mimetic peptides in ovarian cancer","volume":"9","author":"Marinho","year":"2018","journal-title":"Front Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8646","article-title":"Lipid levels in serum and cancerous tissues of colorectal cancer patients","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1089688","article-title":"The apolipoprotein B and apolipoprotein A-I Ratio serves as a strong p rognostic factor for the overall survival of patients with colorectal cancer","volume":"12","author":"Pan","year":"2023","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12885-016-2502-z","article-title":"High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0174-2","article-title":"Clinical significance of APOB inactivation in hepatocellular carcinoma","volume":"50","author":"Lee","year":"2018","journal-title":"Exp Mol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","article-title":"ACLY facilitates colon cancer cell metastasis by CTNNB1","volume":"38","author":"Wen","year":"2019","journal-title":"J Exp Clin Cancer research: CR"},{"key":"B37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-023-02656-7","article-title":"Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress","volume":"42","author":"Hu","year":"2023","journal-title":"J Exp Clin Cancer research: CR"},{"key":"B38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.024","article-title":"Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer","volume":"513","author":"Dai","year":"2021","journal-title":"Cancer Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","article-title":"Nuclear acetyl-coA production by ACLY promotes homologous recombination","volume":"67","author":"Sivanand","year":"2017","journal-title":"Mol Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-12-0095","article-title":"ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms","volume":"11","author":"Zaidi","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation stabilizes ATP-citratelyase to promote lipid biosynthesis and tumor growth","volume":"51","author":"Lin","year":"2013","journal-title":"Mol Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7150\/thno.63417","article-title":"Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i25.4053","article-title":"Molecular profiling reveals potential targets in cholangiocarcinoma","volume":"29","author":"Liu","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/s41467-020-15684-0","article-title":"Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance","volume":"11","author":"Roumans","year":"2020","journal-title":"Nat Commun"},{"key":"B45","article-title":"Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro","volume":"13","author":"Medes","year":"1953","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-09-3871","article-title":"De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation","volume":"70","author":"Rysman","year":"2010","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discovery"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/jci139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1477267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T04:24:11Z","timestamp":1727411051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1477267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2024.1477267"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1477267","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"article-number":"1477267"}}